Hart Kyle, Medvecz Andrew J, Vaidya Avi, Dusetzina Stacie, Leech Ashley A, Wiese Andrew D
Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Trauma Surg Acute Care Open. 2024 Jul 14;9(1):e001364. doi: 10.1136/tsaco-2024-001364. eCollection 2024.
Non-opioid analgesics are prescribed in combination with opioids among patients with long bone fracture to reduce opioid prescribing needs, yet evidence is limited on whether they reduce the risk of serious opioid-related events (SOREs). We compared the risk of SOREs among hospitalized patients with long bone fracture discharged with filled opioid prescriptions, with and without non-opioid analgesics.
We identified a retrospective cohort of analgesic-naïve adult patients with a long bone fracture hospitalization using the Merative MarketScan Commercial Database (2013-2020). The exposure was opioid and non-opioid analgesic (gabapentinoids, muscle relaxants, non-steroidal anti-inflammatory drugs, acetaminophen) prescriptions filled in the 3 days before through 42 days after discharge. The outcome was the development of new persistent opioid use or opioid use disorder during follow-up (day 43 through day 408 after discharge). We used Cox proportional hazards regression with inverse probability of treatment weighting with overlap trimming to compare outcomes among those that filled an opioid and a non-opioid analgesic to those that filled only an opioid analgesic. In secondary analyses, we used separate models to compare those that filled a prescription for each specific non-opioid analgesic type with opioids to those that filled only opioids.
Of 29 489 patients, most filled an opioid prescription alone (58.4%) or an opioid and non-opioid (22.0%). In the weighted proportional hazards regression model accounting for relevant covariates and total MME, filling both a non-opioid analgesic and an opioid analgesic was associated with 1.63 times increased risk of SOREs compared with filling an opioid analgesic only (95% CI 1.41 to 1.89). Filling a gabapentin prescription in combination with an opioid was associated with an increased risk of SOREs compared with those that filled an opioid only (adjusted HR: 1.84 (95% CI1.48 to 2.27)).
Filling a non-opioid analgesic in combination with an opioid was associated with an increased risk of SOREs after long bone fracture.
Level III, prognostic/epidemiological.
Retrospective cohort study.
在长骨骨折患者中,非阿片类镇痛药与阿片类药物联合使用,以减少阿片类药物的处方需求,但关于它们是否能降低严重阿片类药物相关事件(SOREs)风险的证据有限。我们比较了开具了阿片类药物处方出院的长骨骨折住院患者中,使用和未使用非阿片类镇痛药的患者发生SOREs的风险。
我们使用默克多市场扫描商业数据库(2013 - 2020年),确定了一组未曾使用过镇痛药的成年长骨骨折住院患者的回顾性队列。暴露因素为出院前3天至出院后42天内开具的阿片类和非阿片类镇痛药(加巴喷丁类药物、肌肉松弛剂、非甾体抗炎药、对乙酰氨基酚)处方。结局是随访期间(出院后第43天至第408天)出现新的持续阿片类药物使用或阿片类药物使用障碍。我们使用Cox比例风险回归,采用带重叠修剪的治疗权重逆概率法,比较开具了阿片类和非阿片类镇痛药的患者与仅开具阿片类镇痛药的患者的结局。在二次分析中,我们使用单独的模型,比较开具每种特定非阿片类镇痛药处方并联合使用阿片类药物的患者与仅使用阿片类药物的患者。
在29489例患者中,大多数患者仅开具了阿片类药物处方(58.4%)或同时开具了阿片类和非阿片类药物处方(22.0%)。在考虑相关协变量和总吗啡毫克当量的加权比例风险回归模型中,与仅开具阿片类镇痛药相比,同时开具非阿片类镇痛药和阿片类镇痛药与SOREs风险增加1.63倍相关(95%置信区间1.41至1.89)。与仅开具阿片类药物的患者相比,联合开具加巴喷丁处方和阿片类药物与SOREs风险增加相关(调整后风险比:1.84(95%置信区间1.48至2.27))。
长骨骨折后联合开具非阿片类镇痛药和阿片类药物与SOREs风险增加相关。
III级,预后/流行病学。
回顾性队列研究。